Scientists at the Goethe University in Frankfurt have claimed to have foundthe cause behind the rare blood clots associated with COVID-19 vaccines ofAstraZeneca and Johnson & Johnson (J&J).
German scientists have attributed adenovirus vectors to rare but seriousblood clotting events. Both vaccines use adenovirus vectors which are coldviruses used to deliver genetic instructions for the spike protein of theSARS-COV-2 virus in the body.——————————
The vaccines’ delivery system sends the DNA gene sequences of the spikeprotein into the cell nucleus instead of the cytosol fluid found inside thecell where the virus produces proteins.
Once the DNA gene sequence is delivered in the cell nucleus, certain partsof the spike protein split apart, creating mutant versions, which areunable to bind to the cell membrane where immunization takes place.
The floating mutant proteins are instead secreted by cells into the body,triggering rare but serious blood clots.
German scientists have suggested AstraZeneca and J&J modify the genesequences of COVID-19 vaccines in a way that prevents spike proteins fromsplitting in the cell nucleus.——————————
——————————
Read Top Stories
The UK has recorded 309 cases and 59 deaths from the rare blood clots outof the 33 million people who received the AstraZeneca vaccine. 142 peopleout of 16 million recipients of the AstraZeneca vaccine have suffered therare blood clots in Europe. In the US, 8 people out of the 7.4 millionrecipients of the J&J vaccine developed rare blood clots.
Many countries, mostly in Europe, have temporarily suspended the use ofAstraZeneca and J&J COVID-19 vaccines after cases of rare blood clottingevents came to light.
On the other hand, COVID-19 vaccines developed by Pfizer and Moderna usem-RNA technology. The vaccines’ delivery system sends the DNA genesequences of the spike protein only in the cytosol fluid and not to thenucleus.
German scientists have also termed all mRNA-based COVID-19 vaccines as‘safe.’
